- Home
- RANI vs LICY Comparison
RANI vs LICY Comparison
Compare RANI & LICY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- LICY
- Stock Information
- Founded
- RANI 2012
- LICY 2016
- Country
- RANI United States
- LICY Canada
- Employees
- RANI N/A
- LICY N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- LICY Environmental Services
- Sector
- RANI Health Care
- LICY Industrials
- Exchange
- RANI Nasdaq
- LICY Nasdaq
- Market Cap
- RANI 78.3M
- LICY 83.8M
- IPO Year
- RANI 2021
- LICY N/A
- Fundamental
- Price
- RANI $2.35
- LICY $2.41
- Analyst Decision
- RANI Strong Buy
- LICY Hold
- Analyst Count
- RANI 5
- LICY 3
- Target Price
- RANI $11.80
- LICY $5.36
- AVG Volume (30 Days)
- RANI 832.6K
- LICY 2.3M
- Earning Date
- RANI 11-14-2024
- LICY 11-07-2024
- Dividend Yield
- RANI N/A
- LICY N/A
- EPS Growth
- RANI N/A
- LICY N/A
- EPS
- RANI N/A
- LICY N/A
- Revenue
- RANI N/A
- LICY $27,400,000.00
- Revenue This Year
- RANI N/A
- LICY $48.13
- Revenue Next Year
- RANI N/A
- LICY $18.15
- P/E Ratio
- RANI N/A
- LICY N/A
- Revenue Growth
- RANI N/A
- LICY N/A
- 52 Week Low
- RANI $1.90
- LICY $1.22
- 52 Week High
- RANI $8.75
- LICY $15.36
- Technical
- Relative Strength Index (RSI)
- RANI 47.17
- LICY 46.18
- Support Level
- RANI $2.32
- LICY $2.69
- Resistance Level
- RANI $2.67
- LICY $4.98
- Average True Range (ATR)
- RANI 0.17
- LICY 0.57
- MACD
- RANI 0.01
- LICY -0.04
- Stochastic Oscillator
- RANI 34.02
- LICY 13.60
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
About LICY Li-Cycle Holdings Corp.
Li-Cycle Holdings Corp is a lithium-ion battery resource recovery and lithium-ion battery recycler. The company's proprietary process Spoke and Hub recycling process is designed at its Spokes, to process battery manufacturing scrap and end-of-life batteries to produce black mass and other intermediate products, and at its Hubs, to process black mass to recover raw materials, including but not limited to lithium carbonate, cobalt sulphate, and nickel sulphate.